Cargando…
Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions
OPCML, a tumor suppressor gene, is frequently silenced epigenetically in ovarian and other cancers. Here we report, by analysis of databases of tumor sequences, the observation of OPCML somatic missense mutations from various tumor types and the impact of these mutations on OPCML function, by solvin...
Autores principales: | Birtley, James R., Alomary, Mohammad, Zanini, Elisa, Antony, Jane, Maben, Zachary, Weaver, Grant C., Von Arx, Claudia, Mura, Manuela, Marinho, Aline T., Lu, Haonan, Morecroft, Eloise V. N., Karali, Evdoxia, Chayen, Naomi E., Tate, Edward W., Jurewicz, Mollie, Stern, Lawrence J., Recchi, Chiara, Gabra, Hani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637204/ https://www.ncbi.nlm.nih.gov/pubmed/31316070 http://dx.doi.org/10.1038/s41467-019-10966-8 |
Ejemplares similares
-
OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers
por: Gabra, H
Publicado: (2012) -
Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
por: Marinho, Aline T., et al.
Publicado: (2019) -
OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
por: Cui, Yan, et al.
Publicado: (2008) -
OPCML is hypermethylated in a subset of patients with metaplastic changes in their esophagus
por: Castaño-Rodríguez, Natalia, et al.
Publicado: (2018) -
Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas
and Lymphomas with Frequently Epigenetic Inactivation
por: Cui, Yan, et al.
Publicado: (2008)